Vassilakopoulos TP - Search Results

1

Real-life Experience With Rituximab-CHOP Every 21 or 14 Days in Primary Mediastinal Large B-cell Lymphoma.

Karakatsanis SJ, Bouzani M, Symeonidis A, Angelopoulou MK, Papageorgiou SG, Michail M, Gainaru G, Kourti G, Sachanas S, Kalpadakis C, Katodritou E, Leonidopoulou T, Kotsianidis I, Hatzimichael E, Kotsopoulou M, Dimou M, Variamis E, Boutsis D, Kanellias N, Dimopoulou MN, Michali E, Karianakis G, Tsirkinidis P, Vadikolia C, Poziopoulos C, Pigaditou A, Vrakidou E, Economopoulos T, Kyriazopoulou L, Siakantaris MP, Kyrtsonis MC, Anargyrou K, Papaioannou M, Hatjiharissi E, Vervessou E, Tsirogianni M, Palassopoulou M, Stefanoudaki E, Zikos P, Tsirigotis P, Tsourouflis G, Assimakopoulou T, Verrou E, Papadaki H, Lampropoulou P, Dimopoulos MA, Pappa V, Konstantopoulos K, Karmiris T, Roussou P, Panayiotidis P, Pangalis GA, Vassilakopoulos TP; Hellenic Cooperative Lymphoma Group. Karakatsanis SJ, et al. Among authors: vassilakopoulos tp. In Vivo. 2022 May-Jun;36(3):1302-1315. doi: 10.21873/invivo.12831. In Vivo. 2022. PMID: 35478115 Free PMC article.

2

Clinical approach to lymphadenopathy.

Pangalis GA, Vassilakopoulos TP, Boussiotis VA, Fessas P. Pangalis GA, et al. Among authors: vassilakopoulos tp. Semin Oncol. 1993 Dec;20(6):570-82. Semin Oncol. 1993. PMID: 8296196 Review. No abstract available.

3

B-chronic lymphocytic leukemia, small lymphocytic lymphoma, and lymphoplasmacytic lymphoma, including Waldenström's macroglobulinemia: a clinical, morphologic, and biologic spectrum of similar disorders.

Pangalis GA, Angelopoulou MK, Vassilakopoulos TP, Siakantaris MP, Kittas C. Pangalis GA, et al. Among authors: vassilakopoulos tp. Semin Hematol. 1999 Apr;36(2):104-14. Semin Hematol. 1999. PMID: 10319379 Review.

4

EBVD combination chemotherapy plus low dose involved field radiation is a highly effective treatment modality for early stage Hodgkin's disease.

Angelopoulou MK, Vassilakopoulos TP, Siakantaris MP, Kontopidou FN, Boussiotis VA, Papavassiliou C, Kittas C, Pangalis GA. Angelopoulou MK, et al. Among authors: vassilakopoulos tp. Leuk Lymphoma. 2000 Mar;37(1-2):131-43. doi: 10.3109/10428190009057636. Leuk Lymphoma. 2000. PMID: 10721777 Clinical Trial.

5

Application of a prediction rule to select which patients presenting with lymphadenopathy should undergo a lymph node biopsy.

Vassilakopoulos TP, Pangalis GA. Vassilakopoulos TP, et al. Medicine (Baltimore). 2000 Sep;79(5):338-47. doi: 10.1097/00005792-200009000-00007. Medicine (Baltimore). 2000. PMID: 11039082 Free article.

6

Evaluation of DNA topoisomerase IIalpha expression provides independent prognostic information in non-Hodgkin's lymphomas.

Korkolopoulou P, Angelopoulou M, Siakantari M, Mitropoulos F, Vassilakopoulos T, Zorzos H, Rassidakis G, Androulaki A, Patsouris E, Kittas C, Davaris P, Pangalis GA. Korkolopoulou P, et al. Histopathology. 2001 Jan;38(1):45-53. doi: 10.1046/j.1365-2559.2001.01036.x. Histopathology. 2001. PMID: 11135046

7

Serum interleukin-10 levels are an independent prognostic factor for patients with Hodgkin's lymphoma.

Vassilakopoulos TP, Nadali G, Angelopoulou MK, Siakantaris MP, Dimopoulou MN, Kontopidou FN, Rassidakis GZ, Doussis-Anagnostopoulou IA, Hatzioannou M, Vaiopoulos G, Kittas C, Sarris AH, Pizzolo G, Pangalis GA. Vassilakopoulos TP, et al. Haematologica. 2001 Mar;86(3):274-81. Haematologica. 2001. PMID: 11255274

8

Correction of disease related anaemia of B-chronic lymphoproliferative disorders by recombinant human erythropoietin: maintenance is necessary to sustain response.

Siakantaris MP, Angelopoulou MK, Vassilakopoulos TP, Dimopoulou MN, Kontopidou FN, Pangalis GA. Siakantaris MP, et al. Among authors: vassilakopoulos tp. Leuk Lymphoma. 2000 Dec;40(1-2):141-7. doi: 10.3109/10428190009054891. Leuk Lymphoma. 2000. PMID: 11426615

9

Campath-1H (anti-CD52) monoclonal antibody therapy in lymphoproliferative disorders.

Pangalis GA, Dimopoulou MN, Angelopoulou MK, Tsekouras C, Vassilakopoulos TP, Vaiopoulos G, Siakantaris MP. Pangalis GA, et al. Among authors: vassilakopoulos tp. Med Oncol. 2001;18(2):99-107. doi: 10.1385/mo:18:2:99. Med Oncol. 2001. PMID: 11778765 Review.

10

Waldenström's macroglobulinemia: clinical course and prognostic factors in 60 patients. Experience from a single hematology unit.

Kyrtsonis MC, Vassilakopoulos TP, Angelopoulou MK, Siakantaris P, Kontopidou FN, Dimopoulou MN, Boussiotis V, Gribabis A, Konstantopoulos K, Vaiopoulos GA, Fessas P, Kittas C, Pangalis GA. Kyrtsonis MC, et al. Among authors: vassilakopoulos tp. Ann Hematol. 2001 Dec;80(12):722-7. doi: 10.1007/s00277-001-0385-8. Epub 2001 Oct 30. Ann Hematol. 2001. PMID: 11797112

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259 results

Search Page

Filters